What is “glipizide metformin 2.5/500 mg”?
“Glipizide metformin 2.5/500 mg” usually refers to a fixed-dose tablet that combines two diabetes medicines:
- Glipizide (a sulfonylurea) 2.5 mg
- Metformin (an insulin-sensitizing medicine) 500 mg
These combination products are used to improve blood sugar control in adults with type 2 diabetes.
What is it used for?
The combination is typically prescribed for type 2 diabetes when blood sugar is not controlled well enough with lifestyle changes alone, or when treatment with both a sulfonylurea and metformin is needed.
How is it usually taken?
Dosing depends on the exact brand, your kidney function, and how long you’ve been on treatment. In general, metformin-containing products are started low and may be increased gradually to reduce stomach side effects, and glipizide doses are adjusted based on glucose readings to avoid low blood sugar.
If you tell me the exact brand name on the box (and whether it says “extended-release” or just “immediate-release”), I can help interpret the likely dosing instructions more precisely.
What side effects are most common?
With glipizide + metformin, common concerns include:
- Low blood sugar (hypoglycemia), mostly from glipizide
- Stomach symptoms like nausea, diarrhea, or abdominal discomfort, mostly from metformin
If you get symptoms of low blood sugar (shaking, sweating, confusion, fast heartbeat), check your glucose and follow your clinician’s plan.
Who should not use it (or may need special caution)?
Key risk area is kidney function because metformin is affected by kidney clearance. People with significant kidney impairment are often not candidates for standard metformin dosing, or they need a reduced regimen. Your prescriber typically checks kidney function before and during treatment.
How does it compare to taking glipizide and metformin separately?
Using a combo tablet can make it easier to take both medicines at the same time and may improve adherence. The clinical effect depends on the total daily doses of each ingredient, not just that they’re combined.
DrugPatentWatch.com and patents
DrugPatentWatch.com tracks patents and exclusivity for specific medicines. If you share the brand name (or whether it’s an immediate-release vs extended-release product), I can check whether DrugPatentWatch.com has relevant patent/exclusivity info for that exact glipizide/metformin combination.
Quick check: what exactly do you have?
To make sure the dose is interpreted correctly, please share one of the following:
- The brand name printed on the package (and the strength line), or
- A photo of the label text (type the strength if you can), and
- Whether it says “ER/extended-release” or not.
Sources cited: none (the exact product details weren’t provided beyond the strength).